Add-Vantage
Payments companies reported to CMS as associated with Add-Vantage. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Add-Vantage, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Add-Vantage
These are the largest totals companies reported as associated with Add-Vantage. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Roger Hakimian | Warren, OH | Hematology & Oncology | $21.09 |
| Brittany Mazejko | Youngstown, OH | Nurse Practitioner | $21.09 |
| Sanaullah Khalid | Youngstown, OH | Hematology & Oncology | $21.09 |
| Amy Awaida | Youngstown, OH | Hematology & Oncology | $21.09 |
| Andrew Lerman | Miami, FL | Epilepsy | $20.56 |
| Raul Caballero | Palmetto Bay, FL | Family | $20.56 |
| Charlotte Noorollah | Roslyn Heights, NY | Dermatology | $17.60 |
| Michael Cohen | Stafford, VA | $14.07 | |
| Matthew Frantz | Cleveland, OH | Family Medicine | $13.37 |
| Martin Frantz | Cleveland, OH | Family Medicine | $13.37 |
Prescribed Add-Vantage?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.